Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Scpharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SCPH
Nasdaq
2834
https://www.scpharmaceuticals.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Scpharmaceuticals Inc
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 62%
- Mar 27th, 2024 11:45 am
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
- Mar 16th, 2024 7:57 pm
scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth
- Mar 13th, 2024 9:33 pm
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
- Mar 13th, 2024 8:01 pm
scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
- Mar 6th, 2024 9:01 pm
scPharmaceuticals to Participate in Two Upcoming Investor Conferences
- Feb 28th, 2024 9:01 pm
scPharmaceuticals Inc.'s (NASDAQ:SCPH) Path To Profitability
- Feb 15th, 2024 11:58 am
scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
- Jan 4th, 2024 9:05 pm
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
- Nov 9th, 2023 6:02 pm
scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
- Nov 8th, 2023 9:01 pm
scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
- Nov 1st, 2023 8:05 pm
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 47%
- Oct 19th, 2023 10:34 am
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Oct 5th, 2023 12:00 pm
scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
- Sep 19th, 2023 12:00 pm
scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 5th, 2023 12:00 pm
ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates
- Aug 10th, 2023 9:40 pm
scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
- Aug 10th, 2023 8:01 pm
scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023
- Aug 3rd, 2023 12:00 pm
scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion
- Aug 1st, 2023 12:00 pm
scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes
- Jun 23rd, 2023 12:00 pm
Scroll